These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37072537)

  • 1. [Fear of migraine attacks: diagnosis and treatment].
    Klan T; Diezemann-Prößdorf A; Guth AL; Gaul C; Witthöft M
    Schmerz; 2023 Apr; ():1-8. PubMed ID: 37072537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing attack-related fear in headache disorders-Structure and psychometric properties of the Fear of Attacks in Migraine Inventory.
    Klan T; Bräscher AK; Klein S; Diezemann-Prößdorf A; Guth AL; Gaul C; Witthöft M
    Headache; 2022 Mar; 62(3):294-305. PubMed ID: 35181884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions for acute attacks of vestibular migraine.
    Webster KE; Dor A; Galbraith K; Haj Kassem L; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD015322. PubMed ID: 37042545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalalgiaphobia: a possible specific phobia of illness.
    Peres MF; Mercante JP; Guendler VZ; Corchs F; Bernik MA; Zukerman E; Silberstein SD
    J Headache Pain; 2007 Feb; 8(1):56-9. PubMed ID: 17361383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictability of future attacks by migraineurs: a prospective observational study.
    Hu XH; Golden W; Bolge SC; Katic B; Chen YT; Wagner S; Cady R
    Headache; 2010 Sep; 50(8):1296-305. PubMed ID: 20236350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facing the fear--clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia.
    Liebscher C; Wittmann A; Gechter J; Schlagenhauf F; Lueken U; Plag J; Straube B; Pfleiderer B; Fehm L; Gerlach AL; Kircher T; Fydrich T; Deckert J; Wittchen HU; Heinz A; Arolt V; Ströhle A
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):431-44. PubMed ID: 26837851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Sectional Evaluation of the Psychometric Properties of the Headache-Specific Locus of Control Scale in People With Migraine.
    Grinberg AS; Seng EK
    Headache; 2019 May; 59(5):701-714. PubMed ID: 30784040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in migraine attack characteristics: A longitudinal E-diary study.
    Verhagen IE; van der Arend BWH; van Casteren DS; le Cessie S; MaassenVanDenBrink A; Terwindt GM
    Headache; 2023 Mar; 63(3):333-341. PubMed ID: 36942410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validation and factor analysis of a phobia scale. The French version of the Marks-Mathews fear questionnaire].
    Cottraux J; Bouvard M; Messy P
    Encephale; 1987; 13(1):23-9. PubMed ID: 3582263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
    Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R
    Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study.
    Luedtke K; Basener A; Bedei S; Castien R; Chaibi A; Falla D; Fernández-de-Las-Peñas C; Gustafsson M; Hall T; Jull G; Kropp P; Madsen BK; Schaefer B; Seng E; Steen C; Tuchin P; von Piekartz H; Wollesen B
    BMJ Open; 2020 Feb; 10(2):e029855. PubMed ID: 32051295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of the Fear Questionnaire in differentiating agoraphobia and social phobia.
    Cox BJ; Swinson RP; Shaw BF
    Br J Psychiatry; 1991 Dec; 159():842-5. PubMed ID: 1790455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].
    Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V
    Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey on treatments for primary headaches in 13 specialized juvenile Headache Centers: The first multicenter Italian study.
    Toldo I; Rattin M; Perissinotto E; De Carlo D; Bolzonella B; Nosadini M; Rossi LN; Vecchio A; Simonati A; Carotenuto M; Scalas C; Sciruicchio V; Raieli V; Mazzotta G; Tozzi E; Valeriani M; Cianchetti C; Balottin U; Guidetti V; Sartori S; Battistella PA
    Eur J Paediatr Neurol; 2017 May; 21(3):507-521. PubMed ID: 28082014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Agoraphobia and panic attacks. Biological and behavioral approaches].
    Cottraux J
    Encephale; 1984; 10(1):13-9. PubMed ID: 6145579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological therapies for the prevention of migraine in adults.
    Sharpe L; Dudeney J; Williams ACC; Nicholas M; McPhee I; Baillie A; Welgampola M; McGuire B
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012295. PubMed ID: 31264211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cardiac mechanics and biomarkers during headache attack in migraine patients with aura: a prospective study.
    Gökdeniz T; Kalaycıoğlu E; Altıntaş B
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1321-1331. PubMed ID: 32253565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine associated with panic attacks.
    Ossipova VV; Kolosova OA; Vein AM
    Cephalalgia; 1999 Oct; 19(8):728-31. PubMed ID: 10570728
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.